GRAPE KING BIO LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 156.5 TWD | +0.32% |
|
+0.97% | +0.32% |
| 27/02 | Grape King Bio Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 09/01 | Grape King Bio Hits Record-High Sales of NT$10.64 Billion in 2023 | MT |
| Sales 2024 * | 11.53B 354M 29.51B | Sales 2025 * | 12.07B 370M 30.89B | Capitalization | 23.18B 712M 59.33B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.6B 49.08M 4.09B | Net income 2025 * | 1.67B 51.26M 4.27B | EV / Sales 2024 * | 1.6 x |
| Net cash position 2024 * | 4.74B 145M 12.12B | Net cash position 2025 * | 4.85B 149M 12.42B | EV / Sales 2025 * | 1.52 x |
| P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
14.6
x | Employees | - |
| Yield 2024 * |
4.56% | Yield 2025 * |
4.72% | Free-Float | 78.59% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.32% | ||
| 1 week | +0.97% | ||
| Current month | -1.26% | ||
| 1 month | -2.19% | ||
| 3 months | +0.97% | ||
| 6 months | +3.64% | ||
| Current year | +0.32% |
1 week
154.00
158.50
1 month
153.00162.50
Current year
151.50163.00
1 year
147.50189.00
3 years
120.00191.00
5 years
120.00234.00
10 years
120.00282.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sheng Lin Tseng
CEO | Chief Executive Officer | - | 19/09/19 |
Chun Ming Hung
DFI | Director of Finance/CFO | - | 01/14/01 |
Sheng-Chieh Hsu
CTO | Chief Tech/Sci/R&D Officer | 73 | 04/23/04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hsiu Ling Kao
BRD | Director/Board Member | - | 15/21/15 |
Chih Sheng Chang
BRD | Director/Board Member | - | 16/97/16 |
Sheng Lin Tseng
CEO | Chief Executive Officer | - | 19/09/19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 156.5 | +0.32% | 172,246 |
| 25/24/25 | 156 | -1.27% | 101,003 |
| 24/24/24 | 158 | +0.64% | 125,064 |
| 23/24/23 | 157 | +1.95% | 143,163 |
| 22/24/22 | 154 | -0.65% | 209,258 |
End-of-day quote Taiwan S.E., April 26, 2024
More quotes
Grape King Bio Ltd is a Taiwan-based company mainly engaged in the manufacture and sale of healthcare products and beverages. The company operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The Company operates in Taiwan, mainland China and other markets.
Sector
Food Processing
Calendar
08/05/2024
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
156.5
TWD
Average target price
172.8
TWD
Spread / Average Target
+10.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.32% | 711M | |
| +8.20% | 7.78B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -13.13% | 3.44B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M | |
| -16.45% | 802M |
- Stock Market
- Equities
- 1707 Stock
